Latest news
NICE recommends AstraZeneca's Calquence for two blood cancers in England and Wales - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 13:52:58 GMTNICE Expands First-Line Options for Two Blood Cancers - MedscapeMedscape · Thu, 06 Aug 2026 11:51:08 GMTRebecsinib Clinical Trial Means New Options for Blood Cancer - UC San Diego TodayUC San Diego Today · Wed, 05 Aug 2026 22:21:26 GMT